Proposed Registration Decision PRD2021-07, Cydia pomonella granulovirus isolate V-22 and Madex HP
This summary describes the key points of the evaluation, while the Science evaluation of Proposed Registration Decision PRD2021-07, Cydia pomonella granulovirus isolate V-22 and Madex HP provides detailed technical information on the human health, environmental and value assessments of Cydia pomonella granulovirus isolate V-22 and Madex HP.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Similar records